Table 3 Comparison the MRI characteristics of mucin-produced tumors between the POMT and MOMC groups

Tumor size

22

49

Median (25th percentile and 75th percentile)(mm)

137.85(62.875, 209.75)

68.2(48.6, 98.75)

0.001*

0.923(0.814, 0.977)

Configuration

22

49

0.000*

0.868(0.743, 0.926)

 Cystic lesion

2(9.1%)

6(12.2%)

 Lesion with solid component

19(86.4%)

19(38.8%)

 Solid lesion

1(4.5%)

24(49.0%)

Number of cysts

22

49

0.069

0.799(0.666, 0.877)

 Unicystic

6(27.3%)

9(18.4%)

 Oliocystic

4(18.2%)

23(46.9%)

 Multicystic

12(54.5%)

17(34.7%)

Honeycomb sign

22

49

0.023*

0.802(0.699, 0.873)

 Yes

11(50.0%)

39(79.6%)

No

11(50.0%)

10(20.4%)

Stained-glass appearance

22

49

0.003*

0.818(0.721, 0.883)

 Yes

11(50.0%)

40(81.6%)

 No

11(50.0%)

9(18.4%)

Fluid–fluid level

22

49

0.928

0.853(0.792, 0.907)

 Yes

21(95.5%)

47(95.9%)

 No

1(4.5%)

2(4.1%)

Shading

22

49

0.632

0.767(0.626, 0.855)

 Yes

14(63.6%)

34(69.4%)

 No

8(36.4%)

15(30.6%)

Size diversity ratio

15.04(9.86, 24.58)

5.80(3.31, 7.88)

0.000*

0.807(0.670, 0.886)

Signal intensity diversity ratio

1.72(1.36, 2.74)

1.21(1.09, 1.55)

0.006*

0.823(0.723, 0.903)

Enhancement^a

22

44

0.460

0.647(0.412, 0.786)

 Less than or equal to the myometrium

16(72.7%)

28(63.6%)

 Greater than the myometrium

6(27.3%)

16(36.4%)

Enhanced pattern^a

22

44

0.010*

0.839(0.618, 0.920)

 Low risk

16(72.7%)

24(54.5%)

 Intermediate risk

6(27.3%)

6(13.6%)

 High risk

0(0.00%)

14(31.8%)

ADC value

1.35(1.04, 1.60)

1.16(0.98, 1.52)

0.722

0.907(0.852, 0.942)

Ascites

22

49

0.006*

0.892(0.827, 0.933)

 None or physiological

10(45.5%)

10(20.4%)

 Moderate

10(45.5%)

39(79.6%)

 Massive

2(9.0%)

0(0.00%)